Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07451171 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Comparative Efficacy of Antibiotics for Small Intestine Bacterial Overgrowth in Bangladeshi Children

StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 3 months later Aug 2, 2026 → Nov 2, 2026
See other at-risk trials from University of Virginia

Record History

  1. Primary completion pushed from Aug 2, 2026 to Nov 2, 2026
    • Study completion pushed from Sep 1, 2026 to Dec 2, 2026
    v4
  2. Primary completion pushed from Jun 2026 to Aug 2, 2026
    • Study completion pushed from Jun 2026 to Sep 1, 2026
    • Start date: Apr 15, 2026 to Apr 18, 2026
    v3
  3. Recruitment opened
    • Start date changed from estimate of Apr 2026 to Apr 15, 2026
    • Site details revised
    v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this Phase IIa study is to identify the most effective antibiotic regimen to treat small intestine bacterial overgrowth (SIBO) in impoverished Bangladeshi children.
Trial Details
NCT Number NCT07451171
Lead Sponsor University of Virginia
Collaborators: National Institutes of Health (NIH), International Centre for Diarrhoeal Disease Research, Bangladesh, Virginia Commonwealth University, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Conditions
(from sponsor)		 Small Intestine Bacterial Overgrowth
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov